Clinical Trial Detail

NCT ID NCT03237572
Title Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer (Breast-48)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Patrick Dillon, MD
Indications

breast cancer

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.